A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects

NCT02141425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Pharmacokinetics of ASP015K

Interventions

DRUG: ASP015K
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]